Advertisement

Topics

Physicians’ Education Resource® Hosts "Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology Strategies" Symposium

14:43 EDT 15 May 2018 | Businesswire

Physicians’ Education Resource, LLC

Program will take place during the American Urological Association’s 2018 Annual Meeting

Physicians’ Education Resource® (PER®), the leader in hematology and oncology continuing medical education, will host Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology Strategies. The live educational symposium will be held on May 19 at 5:30 p.m. at the Moscone Center in San Francisco in conjunction with the American Urological Association’s 2018 annual meeting. The program will be chaired by Daniel P. Petrylak, M.D., a professor of medical oncology and urology, the director of prostate and GU medical oncology, and the director of Prostate Cancer Translational Research Group at Yale Cancer Center.

“In recent years, we have seen new data that supports the use of immuno-oncology strategies in the treatment of bladder cancers, a tumor were the standard of care hadn’t changed in quite some time” said Phil Talamo, the president of PER®. “This satellite symposium will help the urologist understand the latest data and integrate new care strategies for their bladder cancer patients.”

Designed for urologists, oncologists and researchers interested in the treatment of bladder cancers, Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology Strategies is an educational symposium. The program provides a review of practice-changing data and its impact on patient care. Attendees will gain insight on immunotherapeutic approaches to managing bladder cancer and patients and the role of biomarkers in contemporary urological cancer care. Attendees will gain insight through real-world interactive clinical case discussions and presentations.

This live CME symposium offers up to 2.0 American Medical Association Physician’s Recognition Award Category 1 Credits™. For more information and to register, visit http://www.gotoper.com/conferences/iobladder18/meetings/advancing-the-treatment-of-bladder-cancers-using-evidence-based-immuno-oncology-strategies.

About PER®:

Since 1995, Physicians’ Education Resource, LLC® (PER®), has been the leading provider of live and online continuing medical education activities on oncology and hematology by providing high-quality, evidence-based activities featuring leading experts who focus on the application of practice-changing advances. In 2018, PER® will develop and implement 20 historic annual legacy conferences in the United States and Europe, along with many world-renowned online learning formats such as Medical Crossfire®. PER is accredited by both the Accreditation Council for Continuing Medical Education (ACCME) and the California Board of Registered Nursing (CBRN). PER® is part of the Cranbury, New Jersey-based MJH Associates, Inc., family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com.

PER® Media:
Theresa Burek, 609-325-4811
tburek@mjhassoc.com
or
Surabhi Verma, 609-716-7777 ext. 851
sverma@mjhassoc.com

NEXT ARTICLE

More From BioPortfolio on "Physicians’ Education Resource® Hosts "Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology Strategies" Symposium"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Bladder Cancer
Non-invasive bladder cancer is a cancer that is only in the inner lining of the bladder. Invasive bladder cancer is cancer that has spread into the deeper walls of the bladder. When the cancer has spread outside the bladder to other parts of the body, th...